These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1260589)

  • 1. Drug surveillance data in a Canadian hospital.
    Borda IT; Napke E; Stapleton C
    Can Med Assoc J; 1976 Mar; 114(6):517-22. PubMed ID: 1260589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions.
    Bennett BS; Lipman AG
    Am J Hosp Pharm; 1977 Sep; 34(9):931-6. PubMed ID: 906995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to drugs in hospitalized medical patients. A comparative study.
    Levy M; Nir I; Birnbaum D; Superstine E; Eliakim M
    Isr J Med Sci; 1973 May; 9(5):617-26. PubMed ID: 4717945
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse reactions from chemotherapeutic drugs in hospitals.
    Borda I
    Int J Clin Pharmacol; 1974 Jun; 9(4):271-5. PubMed ID: 4424027
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse drug reactions in children leading to hospital admission.
    Mitchell AA; Lacouture PG; Sheehan JE; Kauffman RE; Shapiro S
    Pediatrics; 1988 Jul; 82(1):24-9. PubMed ID: 3380598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Zealand Committee on Adverse Drug Reactions: eleventh annual report 1976.
    McQueen EG
    N Z Med J; 1976 Dec; 84(577):450-3. PubMed ID: 14321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmarketing surveillance.
    Oleen MA
    Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions.
    Schumock GT; Thornton JP; Witte KW
    Am J Hosp Pharm; 1991 Sep; 48(9):1974-6. PubMed ID: 1928145
    [No Abstract]   [Full Text] [Related]  

  • 10. A survey of adverse drug reaction reporting programs in select hospitals.
    Case RL; Guzzetti PJ
    Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system.
    Budnitz DS; Pollock DA; Mendelsohn AB; Weidenbach KN; McDonald AK; Annest JL
    Ann Emerg Med; 2005 Feb; 45(2):197-206. PubMed ID: 15671977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions in elderly patients: alternative approaches to postmarket surveillance.
    Noah BA; Brushwood DB
    J Health Law; 2000; 33(3):383-454. PubMed ID: 11184355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of drug adverse reactions.
    Can Med Assoc J; 1972 Mar; 106(5):535-6. PubMed ID: 5021155
    [No Abstract]   [Full Text] [Related]  

  • 14. New drugs: watch out for unexpected adverse effects.
    Prescrire Int; 2002 Oct; 11(61):150-1. PubMed ID: 12378747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric adverse drug reaction reporting: understanding and future directions.
    Carleton BC; Smith MA; Gelin MN; Heathcote SC
    Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug utilization and adverse drug reactions in medical patients: comparison of two periods, 1969--72 and 1973--76.
    Levy M; Kletter-Hemo D; Nir I; Eliakim M
    Isr J Med Sci; 1977 Nov; 13(11):1065-72. PubMed ID: 591300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug associated hepatic reactions in New Zealand: 21 years experience.
    Pillans PI
    N Z Med J; 1996 Aug; 109(1028):315-9. PubMed ID: 8816722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adverse drug reactions on length of stay in surgical intensive care units.
    Vargas E; Terleira A; Hernando F; Perez E; Cordón C; Moreno A; Portolés A
    Crit Care Med; 2003 Mar; 31(3):694-8. PubMed ID: 12626971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacist and adverse drug reaction reporting.
    Pearson K
    Hosp Pharm; 1982 Aug; 17(8):421-2, 427-30. PubMed ID: 10256700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions among inpatients in a north Indian referral hospital.
    Uppal R; Jhaj R; Malhotra S
    Natl Med J India; 2000; 13(1):16-8. PubMed ID: 10743370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.